A leading multinational pharmaceutical company was sending the same generic emails and messages to thousands of doctors — and watching engagement collapse. Open rates had fallen to as low as 1–2%, unsubscribes were climbing, and content rarely matched a doctor’s speciality, interests, or preferred channel. Using Multiplier AI’s Hyper Personalized Content Platform, the company moved from one-size-fits-all blasts to N=1 content built on each doctor’s digital footprint — automatically assembled from approved, compliant modules and delivered across email, WhatsApp, social, and field reps. Campaign engagement rose 35% and patient engagement grew 20%, with double-digit gains even among hard-to-reach rural doctors and GPs.
The company’s content engine was built for volume, not relevance. Marketing produced a single set of materials and pushed it to every doctor, with only light segment-level tweaks. Doctors received content that was technically correct but rarely relevant to them — and they stopped engaging.
The numbers told the story:
- Collapsing email performance — generic blasts to doctors saw open rates as low as 1–2%, and even broad industry pharma email open rates have fallen from ~25% in 2015 to around 5% in 2025, with response rates near 1%.
- Rising unsubscribes — irrelevant, repetitive messaging pushed HCPs to opt out, shrinking the reachable audience with every send.
- No personalization at scale — tailoring content to each doctor’s speciality, therapy interest, and channel preference was manual and impossible across thousands of HCPs.
- Single-channel thinking — outreach leaned on email alone, while doctors increasingly engage on WhatsApp, social, and through field reps.
- Hard-to-reach segments ignored — rural doctors, GPs, and non-performing territories rarely received content that fit their context.
Pharma spends heavily on HCP marketing, yet the vast majority of messages are ignored. Without relevance, every additional send added cost and fatigue — not engagement.
The company deployed Multiplier AI’s Hyper Personalized Content Platform — an AI system that builds N=1 content for each doctor based on their digital footprint, then delivers it across the channels they actually use, all within approved, compliant guardrails.
It worked in four moves:
- Real-time behaviour tracking — the platform analysed each doctor’s digital footprint, engagement history, and channel behaviour to learn what they care about and how they prefer to consume it.
- AI content assembly (not just creation) — instead of writing every asset from scratch, the platform assembled MLR-approved modular blocks — headlines, summaries, data points, CTAs — into relevant variations for each HCP cohort, at scale.
- Omnichannel delivery — personalized content flowed across email, WhatsApp, social, and field reps, so each doctor received the right message on their preferred channel.
- Compliance by design — every variation stayed within approved content, with consent, data minimisation, and audit trails aligned to DPDP and UCPMP (India) and GDPR and HIPAA (global).
The platform runs on a clean data foundation — the same doctor intelligence powering Multiplier AI’s GenAI Doctor Data Platform — and uses GPT & LLM-based tools to assemble approved content, continuously learning from engagement to improve the next message.
Within 30–60 days, relevance replaced noise — and engagement followed.
- 35% higher campaign engagement — personalized, context-aware content lifted overall campaign engagement and effectiveness by 35%.
- 20% growth in patient engagement — more relevant HCP communication translated into stronger downstream patient engagement.
- 18% more engagement from rural doctors & GPs — content that fit local context reached audiences generic blasts had missed.
- 12% more prescriptions from non-performing territories — relevance reopened territories that had gone quiet.
- Healthier channels — open and response rates recovered as doctors received fewer, more relevant messages instead of repetitive blasts.
Personalization at N=1 didn’t just improve a metric — it expanded reach into new towns and cities and made every campaign work harder.
Why Generic Pharma Content Stopped Working
For years, pharma marketing scaled by sending one message to many doctors. That model has broken. Doctors are flooded with look-alike emails that ignore their speciality and interests, so they stop opening them. Generic blasts now see open rates as low as 1–2%, broad industry email opens have fallen from ~25% in 2015 to around 5% in 2025, and repetitive messaging drives unsubscribes. The problem was never the value of personalization — it was achieving it at scale.
What “N=1” Hyper-Personalization Really Means
N=1 means content built for one doctor at a time, based on their digital footprint — not broad segments. Multiplier AI’s Hyper Personalized Content Platform reads signals like speciality, therapy-area interest, engagement history, channel preference, and consent status, then assembles MLR-approved modular content into a version that fits each HCP. It is a shift from content creation to AI content assembly — recombining approved blocks into thousands of relevant, compliant variations instead of writing each asset from scratch.
One Doctor, Every Channel — Omnichannel Delivery
Relevance only works if it reaches the doctor where they are. The platform delivers personalized content across email, WhatsApp, social, and field reps, and lets AI choose the best channel for each HCP. The same clean data and content engine keep the message consistent across every touchpoint — true omnichannel, not disconnected multichannel.
From Relevance to Results
Better relevance changed engagement first, then commercial outcomes. Personalized, well-timed content brought doctors back — and reopened audiences that generic blasts had lost. The platform runs on the doctor intelligence of the GenAI Doctor Data Platform, so personalization is built on accurate, consented data rather than guesswork.
Personalization Without Compliance Risk — and Why Pharma Teams Choose Multiplier AI
Personalization at scale must stay compliant. Every variation is built from approved content with claim controls, consent, data minimisation, and audit trails aligned to DPDP, UCPMP, GDPR and HIPAA. Beyond compliance, Multiplier AI is different: privately deployed, healthcare-only AI agents that run content operations end to end, typically showing baseline metrics, improvements, and ROI within 30 to 60 days. Explore more AI solutions for pharma companies or browse other Multiplier AI case studies.
“We stopped blasting doctors and started talking to them. The moment content matched each doctor’s world, engagement came back.”
Generic doesn’t scale — one-size-fits-all blasts pushed doctor open rates to 1–2% and drove unsubscribes.
N=1 is now practical — AI assembles MLR-approved modular content into relevant variations for thousands of HCPs at once.
Relevance lifts the whole funnel — +35% campaign engagement, +20% patient engagement, and new reach into rural and non-performing territories.
Omnichannel beats email-only — meeting doctors on email, WhatsApp, social, and field multiplies engagement.
Ready to See Similar Results?
Talk to our team about your challenges. No pitch — just a real conversation about what you need.
Schedule a 30-Minute Free Consultation →Let's Discuss Your Requirements
